Skip to main content
. 2021 Feb 1;26(6):e925–e935. doi: 10.1002/onco.13668

Figure 4.

Figure 4

(A): The computed tomography (CT) scan of the patient before apatinib showed the uncontrolled primary tumor (white arrow). (B): The patient with tracheal esophageal fistula, 25 days after treatment. (C): The CT scan of the patient before apatinib showed the uncontrolled primary tumor (white arrow). (D): The patient with mediastinoesophageal fistula, 30 days after treatment.